20.74 0.00 (0.00%)
After hours: 4:13PM EDT
|Bid||19.80 x 1300|
|Ask||20.74 x 2200|
|Day's Range||20.42 - 20.80|
|52 Week Range||14.45 - 31.53|
|Beta (3Y Monthly)||1.32|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 26, 2019 - Aug 30, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||23.36|
Hain Celestial (HAIN) is expected to gain from its Project Terra program and acquisitions amid a muted FY19 guidance and soft margins.
Hain Celestial (HAIN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
After the fluctuations of marijuana stocks over the last year, Aphria (NYSE:APHA) stock still trades more than 50% below its 52-week high. Investors sold off Aphria stock, as many questioned whether APHA was a "shell game"after it bought assets in Latin America.However, the executives who drove that purchase have left Aphria. The company has now hired a well-regarded executive as its interim CEO. Due to its current multiple and improved strategic decision-making, Aphria stock could move much higher as the company's reputation improves. * 10 Stocks to Buy That Could Be Takeover Targets Aphria Stock Became Cheap for a ReasonOne of the biggest draws of Aphria Inc over more prominent cannabis players involves its valuation. In a world in which many cannabis stocks have price-sales ratios in the triple digits, Aphria supports a much more reasonable forward price-earnings (PE) ratio of about 21.7.InvestorPlace - Stock Market News, Stock Advice & Trading TipsBut Aphria stock trades at a massive discount to its peers for a good reason. As recently as September, APHA had come close to $17 per share. However, most marijuana stocks sold off after Canada legalized cannabis. Aphria Inc dropped further when Hindenburg Research described it as a "shell game with a cannabis business on the side." Aphria stock fell briefly below $5 per share following Hindenburg's statement. After APHA briefly recovered, it dropped again, and it currently trades just above $6.60 per share. New Management Leaves APHA Well-Positioned for GrowthAs a result of the sharp decline of Aphria stock, founders Vic Neufeld and Cole Cacciavillani left the company. Now, former Hain Celestial (NASDAQ:HAIN) Irwin Simon heads Aphria Inc as the interim CEO.Under Simon, the company continues to focus on ramping up its production, to the point where it will be the third-highest cannabis behind only Canopy Growth (NYSE:CGC) and Aurora Cannabis (NYSE:ACB). Production at its Aphria One plant in Canada has now reached 115,000 kg . Upon completion of a new plant, that total could reach over 250,000 kg.Also, while Aphria Inc has divested from the U.S., it now operates in ten countries. In addition to its assets in Latin America, Aphria Inc has a meaningful presence in the large German market, as it has acquired the legal maximum of five cultivation licenses in Germany. APHA has become the only producer legally allowed to grow all three of the marijuana strains that have been approved by German regulators.During his time at Hain, Simon built a reputation for growing companies. Simon founded Hain and led it through most of its 26-year history. Today, Hain stock has a market cap of over $2 billion, and the company owns dozens of natural-product brands.However, Simon is 60 years old and was given the title of interim CEO. That creates uncertainty for Aphria stock, but it also provides the company with the chance to hire a new, top-notch CEO who can repair its reputation. Low Valuation and Potential Takeover TargetUnlike most of its peers, APHA earns a profit, and its trailing price-earnings ratio is only 22, which is quite low for a marijuana stock . Analysts, on average, predict its earnings per share will increase by 140% this year and 75% in fiscal 2020. Even if APHA was not selling cannabis, 21.7 would be a low PE ratio, given its growth. Also, since it operates in an industry with triple-digit price-sales ratios, the multiple of APHA stock can surge tremendously.Moreover, Aphria Inc's low valuation, production capacity, and strong presence in Germany make it a buyout target. Cannabis players may feel some pressure to try to buy APHA before the multiple of Aphria stock inevitably expands. This factor by itself may make taking a chance on Aphria stock worth the risk. Final Thoughts on Aphria StockIf APHA can restore its reputation, Aphria stock could rise tremendously. APHA trades at a steep discount to its peers, due to last year's allegations. However, it's also well-positioned to become one of the industry's top producers. Moreover, its position in Germany's market will bolster its earnings growth. If APHA's multiple expands to levels that are comparable to those of other cannabis stocks, the owners of Aphria stock will see huge gain, assuming another firm does not buy APHA first.As of this writing, Will Healy is long APHA stock. You can follow Will on Twitter at @HealyWriting. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * The 4 FANG Stocks Won't Be Bitten By Regulation Threats * 10 Stocks to Buy That Could Be Takeover Targets * 4 Big Bank Stocks Rebounding Compare Brokers The post Aphria Stock Could Deliver Massive Gains appeared first on InvestorPlace.
Anyone researching The Hain Celestial Group, Inc. (NASDAQ:HAIN) might want to consider the historical volatility of...
Hain Celestial Group Inc NASDAQ/NGS:HAINView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is moderate Bearish sentimentShort interest | NeutralShort interest is moderately high for HAIN with between 10 and 15% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $2.17 billion over the last one-month into ETFs that hold HAIN are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Goods sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Transitions Key Roles to Support Strategic Business Transformation LAKE SUCCESS, N.Y. , May 28, 2019 /PRNewswire/ -- The Hain Celestial Group, Inc. (Nasdaq: HAIN) ("Hain Celestial" or the "Company"), ...
Hain Celestial Group Inc (NASDAQ: HAIN) saw a director return for a few more notable indirect share purchases this past week. The stake was listed as over 4.2 million shares, which compares with more than 105 million shares outstanding.
Hain Celestial Group Inc (NASDAQ: HAIN) had a director make a few more notable indirect share purchases this past week. This maker of organic and natural products recently posted better than expected quarterly results and announced the sale of its interest in Hain Pure Protein for $80 million.
Engaged Capital is a hedge fund that was founded in 2012 by Glenn W. Wellin, who previously sharpened his investment skills at famous Relational Investors where he was a Principal and Managing Director. The fund was launched with an initial capital of $85 million, and it has grown big since – holding $796.16 million in […]
LAKE SUCCESS, N.Y. , May 17, 2019 /PRNewswire/ -- The Hain Celestial Group, Inc. (Nasdaq: HAIN) ("Hain Celestial" or the "Company"), a leading organic and natural products company with ...
No one who follows Aphria (NYSE:APHA stock should have been surprised that the company's president, Jakob Ripshtein, resigned on May 14. Ever since interim CEO Irwin Simon was appointed Independent Chair of Aphria's board in December, it was only a matter of time before Simon, the entrepreneurial founder and former CEO of Hain Celestial (NASDAQ:HAIN), would play a more prominent role at the Canadian cannabis company. Out With the OldSimon stepped down in June 2018 from his role as CEO of Hain after years of sub-standard shareholder returns and a hard-court press from activist investor Engaged Capital.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Stocks to Buy that Lost 10% Last Week Simon owned 1.7% of Hain's stock, but Engaged has an 11.3% stake, so Engaged's founder, Glenn Welling, was appointed to Hain's board in September 2017. Simon remained the chairman of Hain, the same role he now holds at Aphria. At 60 and in reasonably good health, Simon probably isn't ready to devote his life to the golf course and retirement. The resignation of Ripshtein, after Vic Neufeld stepped down as APHA's CEO in January, is another part of the changing of the guard at Aphria. I expect the board to soon remove the interim tag from Simon's current title. The Irwin Simon era at APHA has begun. The New COORipshtein joined Aphria in May 2018 as its chief commercial officer and was promoted to president six months later, before Simon arrived on the scene. While Simon's words of thank to Ripshteins in the company's press release were complimentary, it's clear by Aphria's choice for COO that Simon wasn't comfortable working with Ripshtein, a former CFO of Diageo's (NYSE:DEO) North American operations and former president of the liquor company's Canadian operations. "On behalf of the Board of Directors and Aphria team, we thank Jakob for his contributions to the Company over the past year and wish him well in his future endeavors. He has been instrumental in assembling the incredible team we are fortunate to have today that will carry his responsibilities forward," Irwin stated in Aphria's May 14 press release.The new COO is Jim Meiers, who happens to have come to Aphria after 14 years at Hain Celestial, where he worked alongside Simon. At Hain, Meiers hed several senior executive positions, including president of Celestial Seasonings. Before Hain, he worked at both H.J. Heinz and Kraft Foods. Meiers' hiring suggests two things.First, it's likely Simon wanted someone he could trust to execute Aphria's game plan and someone who's familiar with his style of management. Every change at the top involves a little turnover. I'm sure it wasn't personal. Secondly, Meiers' background suggests that Simon is looking to implement a supply chain which is more appropriate for a food company rather than a medical company. Both, however, require significant oversight, making the appointment a sensible one and positive for Aphria stock. The Bottom Line on Aphria StockThe moves announced May 14 are simply part of the ongoing transformation of Aphria from Vic Neufeld's baby to Irwin Simon's. One of two things is going to happen in the coming months. Either Simon will be appointed the permanent CEO (likely) or Meiers will become the chief executive (less likely but still possible). Given the spotty performance of Hain stock over the past 15 years, I don't know if Simon's rise to power at APHA is, overall, a good thing or a bad thing for the owners of Aphria stock. At the time of this writing Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 10 Retirement Stocks That Won't Wilt in a Bear Market * 5 Consumer Stocks Ready to Push Higher * 3 of the Best ETFs to Buy for a Play on Gold Stocks Compare Brokers The post New Regime Will Impact Aphria Stock appeared first on InvestorPlace.
LAKE SUCCESS, N.Y. , May 14, 2019 /PRNewswire/ -- The Hain Celestial Group, Inc. (Nasdaq: HAIN) ("Hain Celestial" or the "Company"), a leading organic and natural products company with ...
Amid a disappointing earnings report, Aphria (NYSE:APHA) continues on the path to recovery. Allegations regarding an asset purchase and conflicts of interest in the C suite sent Aphria stock from over $16 per share to under $4 per share for a brief time.Source: Shutterstock However, a new CEO has restored some confidence in the company. The most recent earnings numbers stopped the upward move in APHA for now.Still, with a compelling valuation and a well-regarded consumer industry executive leading the company, APHA could find itself on the way to recovery.InvestorPlace - Stock Market News, Stock Advice & Trading TipsFor the sake of full disclosure, I bought Aphria stock when it still traded on the pink sheets. However, I got out soon after it moved to the New York Stock Exchange. I made this decision when questions about conflicts of interest within the C suite and the legitimacy of its Latin American assets came to light. * 7 Dividend Stocks to Buy as the Trade War Reignites A Closer Look at AphriaFast forward to today, and both CEO Vic Neufeld and co-founder and Cole Cacciavillani have left the company. Further, a review of the purchase determined that Aphria paid a high but acceptable price for legitimate assets in Latin America.Aphria has now appointed Irwin Simon as its interim CEO. Simon founded Hain Celestial (NASDAQ:HAIN) in 1993. Over 25 years, he made it one of the leading natural and organic food companies in the U.S. This has helped restore some confidence in APHA. It also mirrors the situation at GE (NYSE:GE) who has also hired a CEO from the outside with a reputation for success.The existence of recent reputational issues tends to breed mistrust. However, it also leaves more risk-tolerant traders with reasons to buy. Aphria stock trades at a forward price-to-earnings (PE) ratio of 22.9.This comes in well below average multiples in the cannabis industry. Today, marijuana stocks often support price-to-sales (PS) ratios in the triple digits. That also appears cheap when considering predicted earnings increases. Wall Street expects profit growth of 140% this year and 75% in fiscal 2020.I think these factors take Aphria back to where it was before the controversies took place. APHA may never catch up to the likes of Canopy Growth (NYSE:CGC) or Aurora Cannabis (NYSE:ACB) in terms of valuation. Still, CGC supports a PS ratio of just over 140. That same multiple stands at around 20 for APHA stock. This leaves APHA will potential to expand that multiple. APHA Is a Buyout CandidateAnother possibility lies in a buyout. his does not mean the hostile bid like the one recently attempted by Green Growth Brands (OTCMKTS:GGBXF), but one from a larger player.I usually avoid recommending stocks for this reason (buyouts can come at any price level). However, given Aphria's low multiple, buyers will likely look to APHA rather than other cannabis firms.Moreover, it has established a presence in key markets offshore. Yes, it recently divested its U.S. assets. However, it holds the holdings in Latin America which caused issues for the company last year. This includes cultivation acreage in Colombia and Jamaica as well as research-related assets in Argentina.Also, its purchase of Nuuvera brings Aphria into Europe, the Middle East, and Africa. Further, it has recently become one of the few firms to acquire five licenses (the legal maximum) to cultivate weed in Germany. This should bring significant growth for APHA even if they never enter the U.S. Bottom Line on Aphria StockNow that the company has put conflicts of interests behind it, a speculative case for Aphria has emerged. Thanks in part to the lower stock price, the company finds itself in a position where it earns an annual profit and trades well below most of its peers in the cannabis industry.Moreover, a CEO with a track record of success runs the company. Also, though it no longer holds U.S. assets, holdings in other parts of the world should lead Aphria to further growth. Regardless of whether owners of APHA benefit from profit growth or a buyout, the future again appears bright for Aphria stock.As of this writing, Will Healy did not hold a position in any of the aforementioned stocks. You can follow Will on Twitter at @HealyWriting. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Dividend Stocks to Buy as the Trade War Reignites * 10 Stocks That Could Squeeze Short Sellers, Including CGC * 5 Tech Stocks Getting Crushed Compare Brokers The post There's a Pretty Strong Speculative Case for Buying Aphria Stock appeared first on InvestorPlace.
Hain Celestial's (HAIN) top and bottom lines decline year over year in third-quarter fiscal 2019. Net sales decline across all regions.
Hain Celestial (HAIN) delivered earnings and revenue surprises of 5.00% and 1.01%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Consumer staples stocks have largely fallen off the radar in recent months. Investors have been much more focused on growth as corporate earnings have pleasantly surprised, the U.S.-China trade spat showed signs of hope and the Federal Reserve decided to keep interest rates steady.Naturally, these more defensive companies haven't been especially red-hot of late. Consumer staples stocks have lagged the marketwide bounce that took shape beginning in late December. But with many other sectors starting to feel the weight of unwieldy gains, and with China trade talks yet again hitting turbulence, the sector might be ready to heat up again.Steve Azoury, founder of financial planning firm Azoury Financial, says, "Consumer staples, the products that people use every day, will always be a big part of America's economy." "The trick," he adds, is identifying the companies that "will stay innovative and update their products and services to excite their customers, and thus the stock prices for investors."Here are 18 of the best consumer staples stocks to invest in at the moment. While some of these are blue-chip stocks that should ring a bell, others are lesser-known companies that serve as the backbone of brands you may be more familiar with. Almost all of them provide varying levels of dividend income. SEE ALSO: 57 Dividend Stocks You Can Count On
The Lake Success, New York-based company said it had a loss of 63 cents per share. Earnings, adjusted to account for discontinued operations and non-recurring costs, were 21 cents per share. The results ...
Transformational Strategic Plan Gaining Traction as Company Reiterates Fiscal Year Guidance Second Consecutive Quarter of Sequential Margin Improvement LAKE SUCCESS, N.Y. , May 9, 2019 /PRNewswire/ -- The ...
LAKE SUCCESS, N.Y., May 9, 2019 /PRNewswire/ -- The Hain Celestial Group, Inc. (HAIN) ("Hain Celestial" or the "Company"), a leading organic and natural products company with operations in North America, Europe, Asia and the Middle East providing consumers with A Healthier Way of Life™, today announced that it has entered into a definitive agreement to sell all of its equity interest in Hain Pure Protein Corporation, which includes the FreeBird™ and Empire® Kosher businesses, to Aterian Investment Partners III, LP for a purchase price of $80 million, subject to adjustments. The transaction is expected to close before June 30, 2019, the end of the Company's fiscal year. "We are pleased to have entered into an agreement for the sale of our remaining Hain Pure Protein businesses," commented Mark L. Schiller, Hain Celestial's President and Chief Executive Officer. "This divestiture is another step forward in simplifying our organization aligned with our transformational strategic plan as we aggressively pursue margin enhancing initiatives to fuel long-term sustainable growth and profitability.
When it comes to marijuana stocks, there always seems to be drama. Hey, it's an industry that is in the hyper growth phase, kind of like what happened during the late 1990s with the dot-coms. But Aphria (NYSE:APHA) has taken the drama to another level. To get a sense of this, just look at the chart. It's been a roller coaster. A year ago, APHA stock went from $8.80 to $14 by September. Then the shares got crushed, plunging to below $6 in early December.Source: Shutterstock Yet this did not mark the end of the volatility of Aphria stock. There was another rally to $10 and yes, the shares would then fall back to $6.Yes, this has been a dream for quick-moving traders. But as for those with a long-term bent, it's been a loser.InvestorPlace - Stock Market News, Stock Advice & Trading TipsSo then why all the volatility? What's going on here? * 10 Great Stocks to Buy on Dips A Closer Look at Aphria StockFirst of all, in December Green Growth Brands (OTCMKTS:GGBXF) launched a buyout bid for the company even though it was much smaller (although, the company had the backing of a billionaire). Yet Green Growth Brands has recently abandoned its buyout effort, and the result was an $89 million payout to Aphria. It appears that a main reason was another example of drama for Aphria stock: its fiscal third quarter earnings report. Simply put, it was downright awful.The company reported a net loss of 20 cents a share and revenues of 74 million CAD. On the other hand, the Street was looking for a more modest loss of 4 cents a share and revenues of 83 million CAD. On the news, Aphria stock dropped about 15%.But this was not the end of the bad news! In response to negative reports from various short sellers, Aphria set up an independent special committee for an investigation of the allegations.The conclusion? Well, it was mixed. On the positive side, the board noted that the assets purchased in Latin America were not a sham (although, the valuations were certainly at high levels). On the negative side, there were examples of conflicts of interest with senior executives, and the CEO and co-founder have since departed.Irwin Simon has come in to take the post as interim CEO. Keep in mind that he has a strong resume, with more than 20 years as the head of Hain Celestial (NASDAQ:HAIN). He looks like the right person to bring some stability to Aphria. Bottom Line on Aphria StockThe growth prospects for cannabis remain strong. According to a research report from the United Nations, the spending is about $150 billion per year. But of course, the near-term opportunity is in Canada, which is expected to see 4.3 billion CAD this year. And in the coming years, we'll likely see more countries legalize cannabis for recreational purposes.There is also the emerging opportunity for cannabidiol (CBD), which is a compound that has shown medical efficacy (such as for pain). In last year's Farm Bill, Congress removed this from the illegal substance list. This is likely to unleash growth in CBD spending in the US.Yet despite all this, I think investors need to be selective with marijuana stocks. And for the most part, there seem to be better alternatives than Aphria stock. Again, the company has to deal with a wrenching transition with its leadership, which will take time, and the financials have been underwhelming.I'd instead look at companies like Cronos (NASDAQ:CRON) and Canopy Growth (NYSE:CGC). They not only have strong production and distribution channels but also the benefit of big-time strategic backers like Altria (NYSE:MO) and Constellation (NYSE:STZ) respectively. Such advantages will definitely make it difficult for other players like Aphria to get an edge.Tom Taulli is the author of High-Profit IPO Strategies, All About Commodities and All About Short Selling. Follow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Great Stocks to Buy on Dips * 6 Growth Stocks to Buy for the Rest of 2019 * 4 Mega-Cap Stocks to Sell Before They Melt Down Compare Brokers The post Aphria Stock Just Has Too Much Drama and Not Enough Value appeared first on InvestorPlace.